Form 4: AnaptysBio Director John P. Schmid Reports Stock Transactions
SEC Form 4 Filing
Director John P. Schmid reports the acquisition and disposal of AnaptysBio common stock and restricted stock units on June 15, 2024.
Summary
- On June 15, 2024, John P. Schmid, a director of AnaptysBio, Inc., reported transactions involving the company's common stock and restricted stock units (RSUs).
- Schmid acquired 3,900 shares of common stock through the vesting of RSUs.
- Simultaneously, Schmid disposed of 3,900 shares of common stock.
- Following these transactions, Schmid beneficially owns 3,900 shares of common stock directly.
- The RSUs vested on the date of the Issuer's 2024 annual meeting of shareholders, contingent upon Schmid's continued service to the Issuer.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by a company director, indicating a neutral sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 06/15/2024 | Date of stock and RSU transactions. |
| 06/18/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.